vimarsana.com
Home
Live Updates
Alnylam Sees FY Non-GAAP Operating Loss To Be Substantially
Alnylam Sees FY Non-GAAP Operating Loss To Be Substantially
Alnylam Sees FY Non-GAAP Operating Loss To Be Substantially Improved
WASHINGTON (dpa-AFX) - Alnylam Pharmaceuticals Inc. (ALNY) said that it expects its full year 2021 non-GAAP operating loss to be substantially improved relative to the prior year.As of on December
Related Keywords
Washington ,
United States ,
,
Alnylam Pharmaceuticals Inc ,
Alnylam ,
Fees ,
Aap ,
Operating ,
Boss ,
Substantially ,
Mproved ,